Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study
CONCLUSIONS: Dual antithrombotic therapy is associated with a substantially lower risk of clinically relevant bleeding without a statistically significant penalty in ischaemic events.PMID:35370126 | DOI:10.4244/EIJ-D-21-00703
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Authors: Willem Lambertus Bor Anne Johanna Wilhelmina de Veer Renske H Olie Sem A O F Rikken Dean R P P Chan Pin Yin Jean Paul R Herrman Mathias Vrolix Martijn Meuwissen Tom Vandendriessche Carlos van Mieghem Michael Magro Naoual Bennaghmouch Rick Hermanides Tom A Source Type: research
More News: Academia | Angioplasty | Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular & Thoracic Surgery | Coronary Angioplasty | Heart | Heart Attack | Heart Valve Disease | Heart Valves | Ischemic Stroke | Percutaneous Coronary Intervention | Statistics | Stroke | Study | Thrombosis | Vitamin K | Vitamins